资讯
4 天on MSN
A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...
Dr. Naveen Chandra G SHOD and Lead Consultant - Department of Interventional Cardiology, Aster Whitefield Hospital, Bengaluru ...
3 天
News-Medical.Net on MSNDT-109 shows promise in treating atherosclerosis and liver diseaseA drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果